Reporte zur Charge FN74Z

Symptomtext

administered to a patient after the expiration date; boostrix vaccine has been given to neonate; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a neonate male patient who received DTPa (Reduced antigen) (Boostrix) (batch number FN74Z, expiry date 28th November 2021) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 6th December 2021, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 6th December 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced expired vaccine used and inappropriate age at vaccine administration. On an unknown date, the outcome of the expired vaccine used and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The reporter stated that, the Boostrix was administered to a neonate patient after the expiration date, which led to expired vaccine used and inappropriate age at vaccine administration. The reporter consented to follow up via postal.